SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Southside Bancshares increased total authorized shares to 88 million, consisting of 80 million common shares and 8 million preferred shares. The amendment expands the company's fin…
The company amended its Series C Convertible Redeemable Preferred Stock designation to set a mandatory redemption maturity date of February 28, 2028, with redemption payable in cas…
The FDA has issued a warning to retailers selling illegal tobacco products that are designed to resemble common everyday items. The agency is cracking down on these deceptive produ…
Effective May 20, 2026, Torchlight Loan Services will assume special servicing duties for the Bravern Office Commons mortgage loan under the BAMLL 2020-BOC securitization agreement…
Hills Bancorporation filed an amendment to its restated articles of incorporation with the SEC. The filing reflects corporate governance updates with potential implications for sha…
Ionetix Corporation restated its Audit Committee Charter to establish governance standards for financial oversight and auditor management. The amendment reinforces independent dire…
AGL Private Credit Income Fund filed an updated limited liability company agreement for its Enhanced PC Income I entity. The filing establishes governance, capital management, and …
Euronet Worldwide submitted an exhibit filing with the Securities and Exchange Commission. The filing appears to be a standard regulatory disclosure requirement for publicly traded…
CONMED Corporation amended and restated its bylaws to allow stockholder meetings via remote communication and establishes 25% ownership threshold for stockholder-requested special …
Telomir Pharmaceuticals announced peer-reviewed publication of preclinical data demonstrating that Telomir-Zn produced dose-dependent survival improvements and reduced hepatic copp…
Immunovant announced positive Week 16 results from its IMVT-1402 trial in difficult-to-treat rheumatoid arthritis, with response rates of 72.7% ACR20, 54.5% ACR50, and 35.8% ACR70.…
Monopar Therapeutics announced publication of Phase 2 study results demonstrating ALXN1840 (tiomolibdate choline) achieved statistically significant reductions in daily copper bala…
Enovis filed a third amendment to its 2020 Omnibus Incentive Plan requesting shareholder approval to increase available shares from approximately 4.3M to 7.97M, effective pending a…
FormFactor filed an amended and restated certificate of incorporation that consolidates existing provisions without material changes to corporate structure or authority. The restat…
Viper Energy, Inc. filed its second amended and restated certificate of incorporation with Delaware, establishing authorized capital of 2.1 billion shares across Class A common, Cl…
Bed Bath & Beyond amended its certificate of incorporation to raise authorized Common Stock from an unspecified prior amount to 200 million shares, with Preferred Stock authorizati…
Lamar Advertising Company filed a proposal to amend and restate its 1996 Equity Incentive Plan, increasing the available share reserve to 19,500,000 shares of Class A Common Stock.…
Medpace Holdings, Inc. filed a restated certificate of incorporation with Delaware, maintaining its authorized capital structure of 250 million common shares and 5 million preferre…
Lipocine announced that Phase 3 clinical data for LPCN 1154, an oral brexanolone candidate for postpartum depression, was accepted for oral and poster presentations at the American…
Relay announced initial Phase 2 data showing zovegalisib achieved a 60% volumetric response rate in PIK3CA-driven vascular anomalies patients at 12 weeks, with 89% investigator-rep…